Checking In on Pacific Biosciences to See If It's Still a Good 'Idea'

Let's review the charts of PACB again.

Does Silk Road Medical Have a Smooth Path Forward?

After gaining a fundamental supporter, here's how aggressive traders could play the stock.

Medtronic Could Touch a New Low as It Bottoms

Let's see what the the charts and indicators look like.

Gilead Sciences Could Retreat Further From Here

Share prices peaked in December.

Boston Scientific's Wicked Rally Can Take the Stock 20% Higher

BSX has rallied the past nine months.

Why Weakness in Sarepta Therapeutics Is Likely to Continue

The trading days between the gaps look like an island surrounded by water.

When Will AbbVie's Long-Term Trend Reassert Itself?

Let's drill down on the charts.

3 High Dividend Healthcare Stocks for Passive Income

These recession-resilient names offer above-average dividend yields and decent growth prospects.

Here's How Innovation Can Drive Apple Higher

The tech giant's stock won a buy rating from Goldman Sachs, and its work on a medical innovation could be a game-changer.

As Covid Threat Weakens, This Biotech Is Still Worth a Shot

Here's a way to trade Vir Biotechnology.